Fig. 9. Inhibition of myosin-II activity diminishes the accumulation of ZYXLIM-GFP at peripheral FAs. Cells expressing ZYXLIM-GFP (B,D) were treated with (C,D) or without (A,B) 100 µM blebbistatin for 30 minutes and were then stained for
5β1 integrin (A,C). Scale bar: 20 µm.